The synthesis of the previously unreported alcohol, 2-fluoro-3-buten-1-ol (1), was accomplished by the reaction of butadiene monoxide with pyridinium poly(hydrogen fluoride). Alcohol 1 was obtained as a mixture with pyridine after distillation. Direct use of the pyridine/fluoroalcohol mixture for reaction with t-butyldiphenylsilyl (TBDPS) chloride gave the silyl ether which was readily purified by silica gel chromatography. Ozonolysis of the silyl ether gave the corresponding fluoroaldehyde. The procedure described offers a useful route to 1 and its derivatives.
The present invention relates to fluorinated 2-aminomethylquinazolinone derivatives that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
The present invention relates to fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine derivatives that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
The synthesis of the previously unreported alcohol, 2-fluoro-3-buten-1-ol (1), was accomplished by the reaction of butadiene monoxide with pyridinium poly(hydrogen fluoride). Alcohol 1 was obtained as a mixture with pyridine after distillation. Direct use of the pyridine/fluoroalcohol mixture for reaction with t-butyldiphenylsilyl (TBDPS) chloride gave the silyl ether which was readily purified by silica gel chromatography. Ozonolysis of the silyl ether gave the corresponding fluoroaldehyde. The procedure described offers a useful route to 1 and its derivatives.